GEV analyst scorecard · GE Vernova
59 rating actions on GEV in the last 12 months. Of 122 price targets that resolved, 75 were reached while they stood, 47 were replaced by the same firm first, and 0 fell short at their deadline. Ratings: 85% Buy-type, 14% Hold-type, 2% Sell-type. Consensus target $1203, 35% above the last close.
Checked through 2026-10-29 · last close $890.12 (2026-10-29). Rebuilt every morning.
What the Holds say: 7 Hold-type ratings on GEV in the last 12 months carried a median target +9% from the price on the day; 14% sat below it.
The 3 upgrades on GEV came after an average +15.5% move in the 30 days before them.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| Jefferies | Buy | 2026-06-11 | $1210 | 5 | 5 | 10 | — |
| Barclays | Overweight | 2026-04-23 | $1250 | 6 | 5 | 11 | 1 of 1 |
| Morgan Stanley | Overweight | 2026-07-23 | $1350 | 5 | 2 | 7 | 1 of 1 |
| RBC Capital | Outperform | 2026-07-23 | $1225 | 5 | 2 | 7 | — |
| Citigroup | Neutral | 2026-10-29 | $1000 | 6 | 1 | 7 | — |
| Goldman Sachs | Buy | 2026-01-29 | $925 | 2 | 4 | 6 | 1 of 1 |
| BNP Paribas | Neutral | 2026-04-27 | $1190 | — | — | 0 | — |
| Rothschild & Co | Buy | 2026-03-09 | $1100 | 1 | 1 | 2 | — |
| Seaport Global | Neutral | 2025-12-11 | — | 1 | 0 | 1 | — |
| Susquehanna | Positive | 2026-10-29 | $1250 | 4 | 6 | 10 | 1 of 1 |
| Bernstein | Outperform | 2026-10-28 | $1298 | 0 | 1 | 1 | — |
| JPMorgan | Overweight | 2026-10-09 | $1150 | 6 | 4 | 10 | 1 of 1 |
| GLJ Research | Sell | 2026-09-14 | $470 | 1 | 2 | 3 | 1 of 1 |
| Evercore ISI Group | Outperform | 2026-04-23 | $1350 | 2 | 0 | 2 | 1 of 1 |
| Wells Fargo | Overweight | 2026-03-31 | $896 | 3 | 2 | 5 | 1 of 1 |
| Oppenheimer | Outperform | 2026-07-23 | $1338 | 2 | 0 | 2 | — |
| TD Cowen | Buy | 2026-10-29 | $1125 | 1 | 2 | 3 | 1 of 1 |
| Guggenheim | Buy | 2026-10-13 | $1450 | 5 | 2 | 7 | 1 of 1 |
| BMO Capital | Outperform | 2026-04-23 | $1250 | 5 | 3 | 8 | 1 of 1 |
| Baird | Outperform | 2026-04-23 | $1400 | 2 | 2 | 4 | — |
| Mizuho | Neutral | 2026-07-27 | $949 | 1 | 1 | 2 | — |
| UBS | Buy | 2025-12-10 | $835 | 2 | 0 | 2 | 1 of 1 |
| Bank of America | Buy | 2025-12-10 | $804 | 4 | 1 | 5 | 1 of 1 |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor GEV carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-10-29 | Citigroup | Neutral | maintained | $890.12 | $1000 | running to 2027-10-29 | -7.5% |
| 2026-10-29 | TD Cowen | Buy | maintained | $890.12 | $1125 | running to 2027-10-29 | -7.5% |
| 2026-10-29 | Susquehanna | Positive | maintained | $890.12 | $1250 | running to 2027-10-29 | -7.5% |
| 2026-10-28 | Bernstein | Outperform | reiterated | $878.03 | $1298 | running to 2027-10-28 | -7.5% |
| 2026-10-14 | Susquehanna | Positive | maintained | $941.78 | $1270 | replaced 2026-10-29, new $1250 | +7.7% |
| 2026-10-13 | Guggenheim | Buy | reiterated | $1004.04 | $1450 | running to 2027-10-13 | +4.9% |
| 2026-10-09 | JPMorgan | Overweight | maintained | $1004.73 | $1150 | running to 2027-10-09 | +5.7% |
| 2026-09-15 | Bernstein | Outperform | reiterated | $882.81 | $1298 | running to 2027-09-15 | -17.0% |
| 2026-09-14 | GLJ Research | Sell | initiated | $874.76 | $470 | running to 2027-09-14 | -17.7% |
| 2026-07-27 | Mizuho | Neutral | maintained | $996.57 | $949 | within 5% of price when set | -4.7% |
| 2026-07-23 | Bernstein | Outperform | maintained | $1031.19 | $1298 | running to 2027-07-23 | -0.4% |
| 2026-07-23 | JPMorgan | Overweight | maintained | $1031.19 | $1330 | replaced 2026-10-09, new $1150 | -0.4% |
| 2026-07-23 | Morgan Stanley | Overweight | maintained | $1031.19 | $1350 | running to 2028-01-23 | -0.4% |
| 2026-07-23 | TD Cowen | Buy | maintained | $1031.19 | $1235 | replaced 2026-10-29, new $1125 | -0.4% |
| 2026-07-23 | RBC Capital | Outperform | maintained | $1031.19 | $1225 | running to 2027-07-23 | -0.4% |
| 2026-07-23 | Oppenheimer | Outperform | maintained | $1031.19 | $1338 | running to 2027-07-23 | -0.4% |
| 2026-07-23 | Guggenheim | Buy | maintained | $1031.19 | $1450 | running to 2027-07-23 | -0.4% |
| 2026-06-17 | Bernstein | Outperform | initiated | $1048.86 | $1206 | replaced 2026-07-23, new $1298 | +3.6% |
| 2026-06-11 | Jefferies | Buy | maintained | $906.79 | $1210 | running to 2027-06-11 | -15.4% |
| 2026-04-27 | BNP Paribas | Outperform → Neutral | downgrade | $1120.23 | $1190 | running to 2027-04-27 | +31.3% |
| 2026-04-24 | Jefferies | Buy | maintained | $1149.19 | $1350 | replaced 2026-06-11, new $1210 | +24.4% |
| 2026-04-23 | RBC Capital | Outperform | maintained | $1149.53 | $1195 | within 5% of price when set | +26.4% |
| 2026-04-23 | TD Cowen | Buy | maintained | $1149.53 | $1220 | replaced 2026-07-23, new $1235 | +26.4% |
| 2026-04-23 | Barclays | Overweight | maintained | $1149.53 | $1250 | running to 2027-04-23 | +26.4% |
| 2026-04-23 | Guggenheim | Buy | maintained | $1149.53 | $1300 | replaced 2026-07-23, new $1450 | +26.4% |
| 2026-04-23 | Evercore ISI Group | Outperform | maintained | $1149.53 | $1350 | running to 2027-04-23 | +26.4% |
| 2026-04-23 | BMO Capital | Outperform | maintained | $1149.53 | $1250 | running to 2027-04-23 | +26.4% |
| 2026-04-23 | Baird | Outperform | maintained | $1149.53 | $1400 | running to 2027-04-23 | +26.4% |
| 2026-04-16 | JPMorgan | Overweight | maintained | $978.32 | $1150 | reached 2026-06-30 | +15.9% |
| 2026-04-16 | Oppenheimer | Outperform | maintained | $978.32 | $1139 | reached 2026-04-23 | +15.9% |
| 2026-04-13 | Citigroup | Neutral | maintained | $991.12 | $1110 | reached 2026-04-22 | +23.1% |
| 2026-04-09 | Susquehanna | Positive | maintained | $968.02 | $1080 | reached 2026-04-22 | +15.3% |
| 2026-04-01 | Barclays | Overweight | maintained | $894.78 | $993 | reached 2026-04-17 | +1.5% |
| 2026-03-31 | Wells Fargo | Overweight | maintained | $872.90 | $896 | within 5% of price when set | -0.1% |
| 2026-03-23 | Morgan Stanley | Overweight | maintained | $882.64 | $960 | reached 2026-04-09 | +6.3% |
| 2026-03-09 | Rothschild & Co | Sell → Buy | upgrade | $830.10 | $1100 | reached 2026-04-22 | +6.5% |
| 2026-01-30 | RBC Capital | Outperform | maintained | $726.37 | $800 | reached 2026-02-09 | +11.1% |
| 2026-01-29 | Goldman Sachs | Buy | maintained | $717.39 | $925 | reached 2026-04-08 | +8.8% |
| 2026-01-29 | Citigroup | Neutral | maintained | $717.39 | $779 | reached 2026-02-03 | +8.8% |
| 2026-01-29 | Susquehanna | Positive | maintained | $717.39 | $820 | reached 2026-02-11 | +8.8% |
| 2026-01-29 | Evercore ISI Group | Outperform | maintained | $717.39 | $905 | reached 2026-03-24 | +8.8% |
| 2026-01-12 | Citigroup | Neutral | maintained | $639.77 | $708 | reached 2026-01-28 | -4.8% |
| 2026-01-12 | GLJ Research | Buy | maintained | $639.77 | $1087 | reached 2026-04-22 | -4.8% |
| 2026-01-09 | Baird | Outperform → Neutral | downgrade | $622.50 | $649 | within 5% of price when set | -13.9% |
| 2026-01-07 | Barclays | Overweight | maintained | $662.32 | $830 | reached 2026-02-19 | +6.5% |
| 2025-12-22 | RBC Capital | Outperform | maintained | $661.81 | $761 | replaced 2026-01-30, new $800 | +19.1% |
| 2025-12-22 | Jefferies | Buy | maintained | $661.81 | $830 | reached 2026-02-19 | +19.1% |
| 2025-12-18 | Jefferies | Hold → Buy | upgrade | $639.43 | $815 | replaced 2025-12-22, new $830 | +15.2% |
| 2025-12-17 | Goldman Sachs | Buy | maintained | $614.19 | $840 | replaced 2026-01-29, new $925 | +6.4% |
| 2025-12-16 | Morgan Stanley | Overweight | maintained | $686.22 | $822 | reached 2026-02-11 | +18.7% |
| 2025-12-16 | Wells Fargo | Overweight | maintained | $686.22 | $831 | reached 2026-02-19 | +18.7% |
| 2025-12-11 | Seaport Global | Buy → Neutral | downgrade | $704.20 | — | no target | +22.2% |
| 2025-12-10 | Oppenheimer | Perform → Outperform | upgrade | $723.00 | $855 | reached 2026-02-24 | +24.7% |
| 2025-12-10 | UBS | Buy | maintained | $723.00 | $835 | reached 2026-02-24 | +24.7% |
| 2025-12-10 | Susquehanna | Positive | maintained | $723.00 | $775 | replaced 2026-01-29, new $820 | +24.7% |
| 2025-12-10 | BMO Capital | Outperform | maintained | $723.00 | $780 | reached 2026-02-03 | +24.7% |
| 2025-12-10 | Bank of America | Buy | maintained | $723.00 | $804 | reached 2026-02-11 | +24.7% |
| 2025-12-04 | Barclays | Overweight | maintained | $629.11 | $720 | reached 2025-12-10 | +14.8% |
| 2025-10-30 | Morgan Stanley | Overweight | maintained | $574.07 | $710 | reached 2025-12-10 | — |
Also in Power & Grid
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.